Literature DB >> 14675110

Eptifibatide-induced thrombocytopenia and circulating procoagulant platelet-derived microparticles in a patient with acute coronary syndrome.

O Morel, L Jesel, M Chauvin, J M Freyssinet, F Toti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14675110     DOI: 10.1111/j.1538-7836.2003.0543f.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  5 in total

Review 1.  Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty.

Authors:  Michael W Tempelhof; Keith H Benzuly; Dan Fintel; Marc Z Krichavsky
Journal:  Tex Heart Inst J       Date:  2012

2.  Eptifibatide-induced thrombocytopenia and thrombosis.

Authors:  Slava Epelman; Deepu Nair; Ross Downey; Mike Militello; Arman T Askari
Journal:  J Thromb Thrombolysis       Date:  2006-10       Impact factor: 2.300

3.  CD235a (Glycophorin-A) Is the Most Predictive Value Among Different Circulating Cellular Microparticles in Thrombocytopenic Human Immunodeficiency Virus Type 1.

Authors:  Nadia El-Menshawy; Mohammed Eissa; Raghada Farag; Ahmed Aboalyazed
Journal:  J Clin Lab Anal       Date:  2015-02-25       Impact factor: 2.352

4.  Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain.

Authors:  Cunji Gao; Brian Boylan; Dan Bougie; Joan C Gill; Jessica Birenbaum; Debra K Newman; Richard H Aster; Peter J Newman
Journal:  J Clin Invest       Date:  2009-02-09       Impact factor: 14.808

5.  A Novel αIIbβ3 Antagonist from Snake Venom Prevents Thrombosis without Causing Bleeding.

Authors:  Yu-Ju Kuo; Ching-Hu Chung; Tzu-Yu Pan; Woei-Jer Chuang; Tur-Fu Huang
Journal:  Toxins (Basel)       Date:  2019-12-21       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.